RE: Good morning! Great week ahead!2 May 2023 17:43
Interesting comparison PM2022 .
What about Bivictrix , a fairly recent AIM addition but with no where near the pipeline and structure of Valirix .
However the MCaps are very close accounting for share price and volume comparison.
Either they are 1 ; heavily overvalued or 2 ; Valirix are seriously undervalued .
My take is on number 2 .
We should find out soon enough .